Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma
Conditions
- Multiple Myeloma (MM)
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- Chimeric Antigen Receptor T-cell
Interventions
- OTHER: autologous hematopoietic stem cell transplantation (ASCT) followed by CAR-T therapy
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Collaborators